Roche (QX) Stock Price - RHHVF

309.25
7.75 (2.57%)
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Roche Holding AG (QX) RHHVF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
7.75 2.57% 309.25 302.06 316.98 302.06 301.50 16:08:54
Bid Price Ask Price Spread Spread % News
309.00 318.91 9.91 3.11% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
20 6,189 $ 311.8065 $ 1,929,770 16,819 254.04 - 399.00
Last Trade Time Type Quantity Stock Price Currency
15:57:32 10 $ 309.25 USD

Roche (QX) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 217.27B 702.56M $ 10.45B - - 702.37M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
159.76k $ - 0.00% - -

more financials information »

Roche (QX) News

Real-Time news about Roche Holding AG (QX) (OTCMarkets): 0 recent articles

Latest RHHVF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RHHVF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week304.02329.9577281.04298.05125,0145.231.72%
1 Month322.80399.00281.04307.0647,422-13.55-4.2%
3 Months323.65399.00281.04309.3817,850-14.40-4.45%
6 Months289.56399.00280.35304.7711,22419.696.8%
1 Year273.702399.00254.04294.078,13635.5512.99%
3 Years256.0725399.00209.55266.236,01353.1820.77%
5 Years274.65399.00209.55263.805,20034.6012.6%

Roche (QX) Description

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).
Your Recent History
USOTC
RHHVF
Roche (QX)
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200330 01:16:30